Hexaware Technologies, a global provider of IT and digital services, has announced a strategic alliance with Abluva, a company focused on securing autonomous AI systems. This collaboration aims to help life sciences companies deploy advanced AI technologies while maintaining strong security, regulatory compliance, and governance.
As AI systems become increasingly integral to areas such as research, clinical trials, patient data handling, and commercial operations, the partnership addresses the growing demand for secure and controlled AI agent deployment. By combining Hexaware’s domain experience with Abluva’s Secure Intelligence Plane, the joint solution is designed to protect sensitive processes while supporting innovation.
The partnership introduces advanced real-time control features through Abluva’s Secure Intelligence Plane, enabling organizations to manage AI agents with greater precision and security. It incorporates mechanisms such as role-based context awareness, data masking, controlled access to tools, and task-specific validation—all aimed at ensuring AI agents operate within defined boundaries and avoid unauthorized actions.
In addition to real-time oversight, the solution delivers comprehensive security across the entire life cycle of an AI agent. From the stages of fine-tuning and data sourcing to the final user interaction and prompt execution, every layer is designed to protect sensitive clinical and research data. This level of coverage is especially critical for life sciences environments where data integrity and confidentiality are paramount.
To further mitigate operational risks, Abluva’s system is equipped with an autonomous response capability that actively detects and corrects abnormal agent behavior. This self-healing technology enables real-time adjustments, reducing reliance on manual intervention and preventing potential disruptions before they escalate into larger issues.
Compliance remains a cornerstone of the solution, with built-in governance tools that support regulatory alignment with global standards such as HIPAA and GDPR. The system also integrates seamlessly with internal oversight policies, offering detailed audit trails and strong privacy controls to help organizations maintain accountability and trust in AI-driven processes.
Raj Gondhali, AVP and Head of Clinical Solutions at Hexaware, said, “This collaboration brings together two critical elements—deep expertise in life sciences and cutting-edge AI security—to provide safe, efficient, and compliant AI implementations for global pharmaceutical sponsors and CROs.”
Abluva CEO Raj Darji added, “Joining forces with Hexaware strengthens our ability to deliver advanced, secure AI systems tailored to life sciences. With our patented technology and Hexaware’s reach, we’re enabling organizations to use agentic AI more safely and confidently.”
Amit Gautam, Chief Technology Officer at Abluva, further noted, “This alliance allows us to bring our security solutions to more complex enterprise environments. Together, we can help companies govern their AI systems more effectively and reduce operational risks.”
This collaboration underscores Hexaware’s ongoing focus on next-generation cloud and AI technologies, while reinforcing Abluva’s leadership in AI security innovation. Together, they aim to enable life sciences companies to embrace intelligent automation with confidence and security.
Hexaware is a global technology and business solutions company, helping enterprises accelerate digital transformation through innovation, process optimization, and cloud solutions. With operations worldwide, the company supports organizations in adapting to modern technology landscapes.
Abluva specializes in advanced security solutions designed for the data economy. The company develops platforms that provide fine-grained data protection, AI agent governance, and compliance-driven tools to manage data usage and AI behavior across industries.
